肺炎链球菌呼吸道感染的再认识  

Further understanding of streptococcus pneumoniae respiratory tract infection

作　　者：刘青[1] 施毅[1] 

机构地区：[1]南京军区南京总医院呼吸与危重症医学科,江苏南京210002

出　　处：《实用医院临床杂志》2013年第4期5-8,共4页Practical Journal of Clinical Medicine

摘　　要：肺炎链球菌至今仍然是社区获得性呼吸道感染的重要病原体,有关肺炎链球菌的研究已经比较广泛而深入。但近年来,在肺炎链球菌的微生物学特性、流行病学、耐药机制及治疗指南等方面都有了新的认识。本文着重介绍近几年肺炎链球菌感染研究的新进展,主要从肺炎链球菌呼吸道感染的现状、青霉素折点的调整、氟喹诺酮耐药特点、生物膜耐药机制及治疗等方面进行阐述。Streptococcus pneumoniae is still an important pathogen of community-acquired respiratory tract infections. Strepto- coccus pneumoniae has been studied widely and deeply. However,in recent years ,there is a new understanding of microbiological char- acteristics, epidemiology, resistance mechanisms and the guidelines of streptococcus pneumoniae treatment. The paper introduces the new progress including the status of streptococcus pneumoniae respiratory tract infection ,revised penicillin breakpoints, fluoroquinolone resistant characteristics, and biofilm resistance mechanisms.

关 键 词：肺炎链球菌 耐药机制 青霉素 氟喹诺酮 生物膜 

分 类 号：R738.14[医药卫生—肿瘤]